The NO donor sodium nitroprusside: Evaluation of skeletal muscle vascular and metabolic dysfunction

Microvascular Research

Volumn 85, Issue 1, 2013, Pages 104-111

  Hirai, Daniel M ^a   Copp, Steven W ^a   Ferguson, Scott K ^a   Holdsworth, Clark T ^a   Musch, Timothy I ^a   Poole, David C ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

FDA; MAP; NO; PO2mv; Q O2; SNP; V O2

Indexed keywords

MICROSPHERE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CYANIDE POISONING; HEMODYNAMICS; ISOTOPE LABELING; MALE; MEAN ARTERIAL PRESSURE; METABOLIC DISORDER; METABOLIC REGULATION; MOUSE; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; MUSCLE FUNCTION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; SKELETAL MUSCLE; TRAPEZIUS MUSCLE; VASCULAR DISEASE; VASODILATATION;

ANIMALS; ARTERIAL PRESSURE; CYANIDES; HEMODYNAMICS; KINETICS; MALE; MICROCIRCULATION; MICROSPHERES; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

RATTUS;

EID: 84871713618     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.11.006     Document Type: Article

References (53)

1. Altman P.L., Dittmer D.S. Biology Data Book 1974, FASEB, Bethesda, MD.
2. Bailey J.K., et al. Spinotrapezius muscle microcirculatory function: effects of surgical exteriorization. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H3131-H3137.
3. Behnke B.J., Delp M.D. Aging blunts the dynamics of vasodilation in isolated skeletal muscle resistance vessels. J. Appl. Physiol. 2010, 108:14-20.
4. Behnke B.J., et al. Dynamics of microvascular oxygen pressure across the rest-exercise transition in rat skeletal muscle. Respir. Physiol. 2001, 126:53-63.
5. Behnke B.J., et al. Dynamics of oxygen uptake following exercise onset in rat skeletal muscle. Respir. Physiol. Neurobiol. 2002, 133:229-239.
6. Behnke B.J., et al. Effects of arterial hypotension on microvascular oxygen exchange in contracting skeletal muscle. J. Appl. Physiol. 2006, 100:1019-1026.
7. Bisset W.I., et al. Sodium nitroprusside and cyanide release: reasons for re-appraisal. Br. J. Anaesth. 1981, 53:1015-1018.
8. Boegehold M.A. Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats. Hypertension 1992, 19:290-295.
9. Butler A.R., et al. Further investigations regarding the toxicity of sodium nitroprusside. Clin. Chem. 1987, 33:490-492.
10. Cohn J.N., et al. Direct-acting vasodilators. J. Clin. Hypertens. (Greenwich) 2011, 13:690-692.
11. Dickstein K., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 2008, 29:2388-2442.
12. Didion S.P., Mayhan W.G. Effect of chronic myocardial infarction on in vivo reactivity of skeletal muscle arterioles. Am. J. Physiol. 1997, 272:H2403-H2408.
13. Ferreira L.F., et al. Muscle microvascular oxygenation in chronic heart failure: role of nitric oxide availability. Acta Physiol (Oxf.) 2006, 188:3-13.
14. Ferreira L.F., et al. Effects of altered nitric oxide availability on rat muscle microvascular oxygenation during contractions. Acta Physiol (Oxf.) 2006, 186:223-232.
15. Friederich J.A., Butterworth J.F.t. Sodium nitroprusside: twenty years and counting. Anesth. Analg. 1995, 81:152-162.
16. Hirai T., et al. Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in rats. J. Appl. Physiol. 1994, 77:1288-1293.
17. Hirai D.M., et al. Aging impacts microvascular oxygen pressures during recovery from contractions in rat skeletal muscle. Respir. Physiol. Neurobiol. 2009, 169:315-322.
18. Hirai D.M., et al. Nitric oxide bioavailability modulates the dynamics of microvascular oxygen exchange during recovery from contractions. Acta Physiol (Oxf.) 2010, 200:159-169.
19. Hirai D.M., et al. Exercise training and muscle microvascular oxygenation: functional role of nitric oxide. J. Appl. Physiol. 2012, 113:557-565.
20. Ignarro L.J., et al. Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. J. Pharmacol. Exp. Ther. 1986, 236:30-36.
21. Ignarro L.J., et al. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ. Res. 2002, 90:21-28.
22. Ishise S., et al. Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am. J. Physiol. 1980, 239:H443-H449.
23. Jones A.M., et al. Inhibition of nitric oxide synthase by L-NAME speeds phase II pulmonary V̇ O2 kinetics in the transition to moderate-intensity exercise in man. J. Physiol. 2003, 552:265-272.
24. Kindig C.A., et al. Nitric oxide synthase inhibition speeds oxygen uptake kinetics in horses during moderate domain running. Respir. Physiol. Neurobiol. 2002, 132:169-178.
25. Lash J.M., Bohlen H.G. Time- and order-dependent changes in functional and NO-mediated dilation during exercise training. J. Appl. Physiol. 1997, 82:460-468.
26. Levy B.I., et al. Role of endothelium in the mechanical response of the carotid arterial wall to calcium blockade in spontaneously hypertensive and Wistar-Kyoto rats. J. Hypertens. 1993, 11:57-63.
27. Lo L.W., et al. A new, water soluble, phosphor for oxygen measurements in vivo. Adv. Exp. Med. Biol. 1997, 428:651-656.
28. Macdonald M., et al. Acceleration of V̇ O2 kinetics in heavy submaximal exercise by hyperoxia and prior high-intensity exercise. J. Appl. Physiol. 1997, 83:1318-1325.
29. Marano G., et al. Endothelin and mechanical properties of the carotid artery in Wistar-Kyoto and spontaneously hypertensive rats. Cardiovasc. Res. 1999, 41:701-707.
30. Miller M.R., et al. Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries. J. Cardiovasc. Pharmacol. 2004, 43:440-451.
31. Muller-Delp J.M., et al. Aging impairs endothelium-dependent vasodilation in rat skeletal muscle arterioles. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1662-H1672.
32. Nagahara N., et al. Mercaptopyruvate sulfurtransferase as a defense against cyanide toxication: molecular properties and mode of detoxification. Histol. Histopathol. 1999, 14:1277-1286.
33. Nightingale S.L. From the food and drug administration. JAMA 1991, 265:847.
34. Padilla J., et al. Relationship between brachial and femoral artery endothelial vasomotor function/phenotype in pigs. Exp. Biol. Med. (Maywood) 2010, 235:1287-1291.
35. Pettersen J.C., Cohen S.D. The effects of cyanide on brain mitochondrial cytochrome oxidase and respiratory activities. J. Appl. Toxicol. 1993, 13:9-14.
36. 2 measured in vivo. J. Appl. Physiol. 1995, 79:2050-2057.
37. Poole D.C., et al. Measurement of muscle microvascular oxygen pressures: compartmentalization of phosphorescent probe. Microcirculation 2004, 11:317-326.
38. Rao D.N., et al. Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch. Biochem. Biophys. 1991, 286:30-37.
39. Rauhala P., et al. Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside. Free Radic. Biol. Med. 1998, 24:1065-1073.
40. Reade M.C., et al. Review article: management of cyanide poisoning. Emerg. Med. Australas. 2012, 24:225-238.
41. Robin E.D., McCauley R. Nitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventions. Chest 1992, 102:1842-1845.
42. Rumsey W.L., et al. Imaging of phosphorescence: a novel method for measuring oxygen distribution in perfused tissue. Science 1988, 241:1649-1651.
43. Saito Y., et al. Role of EDRFs in the control of arteriolar diameter during increased metabolism of striated muscle. Am. J. Physiol. 1994, 267:H195-H200.
44. Sato K., et al. Vasodilation of intramuscular arterioles under shear stress in dystrophin-deficient skeletal muscle is impaired through decreased nNOS expression. Acta Myol. 2008, 27:30-36.
45. Schrage W.G., et al. Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans. J. Physiol. 2004, 557:599-611.
46. Shen W., et al. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995, 92:3505-3512.
47. Shiva S., et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res. 2007, 100:654-661.
48. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001, 81:209-237.
49. Trott D.W., et al. Exercise training reverses age-related decrements in endothelium-dependent dilation in skeletal muscle feed arteries. J. Appl. Physiol. 2009, 106:1925-1934.
50. Varon J., Marik P.E. Clinical review: the management of hypertensive crises. Crit. Care 2003, 7:374-384.
51. Wanstall J.C., et al. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br. J. Pharmacol. 2001, 134:463-472.
52. Way J.L. Cyanide intoxication and its mechanism of antagonism. Annu. Rev. Pharmacol. Toxicol. 1984, 24:451-481.
53. Wood J.L., Cooley S.L. Detoxication of cyanide by cystine. J. Biol. Chem. 1956, 218:449-457.